These discoveries highlight the AMPK/SIRT1/PGC‐1α system as a key controller of diabetes development, presenting new treatment possibilities that target insulin function, sugar processing, and fat regulation through precise pathway adjustments. Here, PRKAA2 is linked to diabetes mellitus.